oral t-therapy/kyzatrex; marius pharma; patent

https://www.globenewswire.com/news-release/2025/03/25/3048815/0/en/Marius-Pharmaceuticals-Strengthens-IP-Portfolio-with-New-KYZATREX-testosterone-undecanoate-CIII-Capsules-Formulation-Patent.html RALEIGH, N.C., March 25, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company...